Bluejay Diagnostics
BJDX
2 hedge funds and large institutions have $98K invested in Bluejay Diagnostics in 2022 Q1 according to their latest regulatory filings, with 1 funds opening new positions, increasing their positions, reducing their positions, and 2 closing their positions.
0% less ownership
Funds ownership: 0% → 0% (-0%)
33% less funds holding
Funds holding: 3 → 2 (-1)
50% less first-time investments, than exits
New positions opened: 1 | Existing positions closed: 2
63% less capital invested
Capital invested by funds: $267K → $98K (-$169K)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
BlackRock
New York
|
+$48.2K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Vanguard Group
Malvern,
Pennsylvania
|
-$82K |
| 2 |
Jane Street
New York
|
-$48.2K |
| 3 |
TSS
Two Sigma Securities
New York
|
-$40K |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
|
PCM
1
Perkins Capital Management
Wayzata,
Minnesota
| $25K | – | – | – |
|
|
2
BlackRock
New York
| $23K | +$48.2K | +1 | New |
|
|
3
Jane Street
New York
| $18K | -$48.2K | -1 | Closed |
|
4
Verition Fund Management
Greenwich,
Connecticut
| $17K | – | – | – |
|
|
TRCT
5
Tower Research Capital (TRC)
New York
| $8K | – | – | – |
|
6
UBS Group
Zurich,
Switzerland
| $6K | – | – | – |
|
7
Osaic Holdings
Scottsdale,
Arizona
| $1K | – | – | – |
|
|
8
Vanguard Group
Malvern,
Pennsylvania
| – | -$82K | -1 | Closed |
|
|
TSS
9
Two Sigma Securities
New York
| – | -$40K | – | – |
|
BJDX Hedge Fund Activity: Q1 2022 in Review
2 of the 6,341 institutional investors tracked by Wall St. Rank reported a position in Bluejay Diagnostics (BJDX) for Q1 2022, worth a combined $98K — down 63% from $267K a quarter earlier.
Sellers outnumbered buyers: 2 funds closed out of BJDX and 1 opened new positions — a net loss of 1 holder — while 0 trimmed existing stakes and 0 added.
The largest buyer was BlackRock, opening a new position worth an estimated $48.2K. The largest seller was Vanguard Group, exiting entirely with an estimated $82K sold.
- 2 institutional investors held Bluejay Diagnostics (BJDX) as of Q1 2022, down from 3 in Q4 2021.
- Funds reported $98K of Bluejay Diagnostics stock for Q1 2022, down 63% quarter-over-quarter.
- 1 fund opened new Bluejay Diagnostics positions in Q1 2022 and 2 closed out, a net change of -1 holder.
- The largest Bluejay Diagnostics buyer in Q1 2022 was BlackRock, an estimated $48.2K added.
- The largest Bluejay Diagnostics seller in Q1 2022 was Vanguard Group, an estimated $82K sold.
Based on aggregated 13F filings for Q1 2022.